In this review, we provide an overview of the US Food and Drug Administration (FDA)-
approved clinical uses of vagus nerve stimulation (VNS) as well as information about the …

Three decades after its introduction as an adjuvant therapeutic option in the management of
selective drug-resistant epilepsy cases (DRE), vagus nerve stimulation (VNS) retains …

Indications for vagus nerve stimulation (VNS) therapy include focal, multifocal epilepsy, drop
attacks (tonic/atonic seizures), Lennox‐Gastaut syndrome, tuberous sclerosis complex …

Objectives: To review relevant literature and present evidence-based guidelines to assist
general and specialist medical practitioners in the evaluation and management of children …

OBJECTIVE The goal of this paper was to investigate surgical and hardware complications
in a longitudinal retrospective study. METHODS The authors of this registry study analyzed …

Dravet syndrome (DS) is a severe, rare, and complex developmental and epileptic
encephalopathy affecting 1 in 16 000 live births and characterized by a drug‐resistant …

Background Cough is one of the most common presenting symptoms to general
practitioners. The objective of this article is to collate the pediatric components of the CHEST …

OBJECTIVE Drug-resistant epilepsy (DRE) presents a therapeutic challenge in children,
necessitating the consideration of multiple treatment options. Although deep brain …

Objective. Previous vagus nerve stimulation (VNS) studies have demonstrated
antinociceptive effects, and recent noninvasive approaches, termed transcutaneous-vagus …

Object The authors undertook this study to analyze the efficacy of vagus nerve stimulation
(VNS) in a large consecutive series of children 18 years of age and younger with treatment …